[HTML][HTML] Randomized assessment of rapid endovascular treatment of ischemic stroke

…, BK Menon, M Eesa, JL Rempel… - … England Journal of …, 2015 - Mass Medical Soc
Background Among patients with a proximal vessel occlusion in the anterior circulation, 60
to 80% of patients die within 90 days after stroke onset or do not regain functional …

Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial

…, D Haussen, SM Cutting, SB Coutts, D Roy, JL Rempel… - The Lancet, 2020 - thelancet.com
Background Nerinetide, an eicosapeptide that interferes with post-synaptic density protein
95, is a neuroprotectant that is effective in preclinical stroke models of ischaemia-reperfusion. …

Analysis of workflow and time to treatment on thrombectomy outcome in the endovascular treatment for small core and proximal occlusion ischemic stroke (ESCAPE) …

BK Menon, TT Sajobi, Y Zhang, JL Rempel, A Shuaib… - Circulation, 2016 - Am Heart Assoc
Background— The Endovascular Treatment for Small Core and Proximal Occlusion Ischemic
Stroke (ESCAPE) trial used innovative imaging and aggressive target time metrics to …

Acute ischemic stroke with tandem lesions: technical endovascular management and clinical outcomes from the ESCAPE trial

…, AM Demchuk, J Shankar, JL Rempel… - Journal of …, 2018 - jnis.bmj.com
Background Tandem occlusions of the extracranial carotid and intracranial carotid or middle
cerebral artery have a particularly poor prognosis without treatment. Several management …

Healthy life-year costs of treatment speed from arrival to endovascular thrombectomy in patients with ischemic stroke: a meta-analysis of individual patient data from 7 …

…, AM Demchuk, BK Menon, M Eesa, JL Rempel… - JAMA …, 2021 - jamanetwork.com
Importance The benefits of endovascular thrombectomy (EVT) are time dependent. Prior
studies may have underestimated the time-benefit association because time of onset is …

Infarct in a new territory after treatment administration in the ESCAPE randomized controlled trial (endovascular treatment for small core and anterior circulation …

A Ganesh, FS Al-Ajlan, F Sabiq, Z Assis, JL Rempel… - Stroke, 2016 - Am Heart Assoc
Background and Purpose— Infarct in a new previously unaffected territory (INT) is a potential
complication of endovascular treatment. We applied a recently proposed methodology to …

Prognostic evaluation based on cortical vein score difference in stroke

R Parthasarathy, M Kate, JL Rempel, DS Liebeskind… - Stroke, 2013 - Am Heart Assoc
Background and Purpose— Multimodal imaging in acute ischemic stroke defines the extent
of arterial collaterals, resultant penumbra, and associated infarct core, yet limitations abound…

Intra-arterial therapy and post-treatment infarct volumes: insights from the ESCAPE randomized controlled trial

…, Z Assis, R Willinsky, WJ Montanera, JL Rempel… - Stroke, 2016 - Am Heart Assoc
Background and Purpose— The goal of reperfusion therapy in acute ischemic stroke is to limit
brain infarction. The objective of this study was to investigate whether the beneficial effect …

Which acute ischemic stroke patients are fast progressors? Results from the ESCAPE trial control arm

…, A Mayank, D Dowlatshahi, D Frei, JL Rempel… - Stroke, 2021 - Am Heart Assoc
Background and Purpose: Fast infarct progression in acute ischemic stroke has a severe
impact on patient prognosis and benefit of endovascular thrombectomy. In this post hoc …

Infarcts in a new territory: insights from the ESCAPE-NA1 trial

…, RA McTaggart, AM Demchuk, AY Poppe, JL Rempel… - Stroke, 2023 - Am Heart Assoc
Background: Infarct in a new territory (INT) is a known complication of endovascular stroke
therapy. We assessed the incidence of INT, outcomes after INT, and the impact of concurrent …